Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 4/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | THPO | P40225 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9435540 | 0.86 | TP53 (0.42) | TP53TSHRALDH1A1 | |
| SCHEMBL6072620 | 0.80 | TSHR (0.50) | TP53TSHRALDH1A1 | |
| SCHEMBL447234 | 0.80 | TP53 (0.47) | TP53TSHRALDH1A1 | |
| SCHEMBL8163675 | 0.78 | TP53 (0.32) | TP53TSHR | |
| SCHEMBL8975401 | 0.78 | TSHR (0.31) | TSHR | |
| SCHEMBL1018572 | 0.78 | — | — | |
| SCHEMBL31019979 | 0.77 | TP53 (0.44) | TP53TSHRALDH1A1 | |
| SCHEMBL28763748 | 0.77 | TP53 (0.44) | TP53TSHRALDH1A1 | |
| SCHEMBL371443 | 0.77 | TP53 (0.44) | TP53TSHRALDH1A1 | |
| SCHEMBL2131856 | 0.77 | TP53 (0.44) | TP53TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 322 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113271931-A | New application of carbamate beta phenylethanolamine analogue in enhancing clearance of intracellular LDL cholesterol and combination with statins | 谭文 | 2021-08-17 | — | — | CN | claimed |
| CN-109280032-A | A kind of histon deacetylase (HDAC) inhibitor and its preparation method and application of pyridazinone mother nucleus structure | 中国科学院上海药物研究所 | 2019-01-29 | — | — | CN | claimed |
| CN-101579625-A | Catalyst and reaction process for preparing pyruvic acid by lactic acid in catalytic oxydehydrogenation way | UNIV HUNAN (CN) | 2009-11-18 | — | — | CN | claimed |
| US-20240238255-A1 | KL1333 FOR USE IN MEDICINE | YUNGJIN PHARM. CO., LTD (KR) | 2024-07-18 | — | — | US | disclosed |
| US-12012437-B2 | Methods of treating mitochondrial disorders | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-06-18 | — | — | US | disclosed |
| CN-114732007-B | Sperm cell process, apparatus and related media compositions | 英格朗公司 | 2024-04-12 | — | — | CN | disclosed |
| EP-4350323-A2 | SYSTEM FOR PREPARING AN OUTPUT SAMPLE COMPRISING A DEFINED CONCENTRATION OF AN INFECTIOUS AGENT FOR DOWNSTREAM TESTING | Avails Medical, Inc. (US) | 2024-04-10 | — | — | EP | disclosed |
| EP-3968021-B1 | SYSTEM FOR PREPARING AN OUTPUT SAMPLE COMPRISING A DEFINED CONCENTRATION OF AN INFECTIOUS AGENT FOR DOWNSTREAM TESTING | AVAILS MED INC (US) | 2024-04-03 | — | — | EP | disclosed |
| EP-4340831-A1 | KL1333 FOR USE IN MEDICINE | Abliva AB (SE) | 2024-03-27 | — | — | EP | disclosed |
| CN-117597429-A | Method and system for assessing the quality of flow dynamics in sperm-containing samples | 康奈尔大学 | 2024-02-23 | — | — | CN | disclosed |
| US-20240042440-A1 | METHODS FOR EVALUATING RHEOTAXIS QUALITY IN A SPERM-CONTAINING SAMPLE AND SYSTEMS THEREFOR | CORNELL UNIVERSITY | 2024-02-08 | — | — | US | disclosed |
| US-4445500-A | Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders | THOMAS JEFFERSON UNIVERSITY (US) | 1984-05-01 | — | — | US | disclosed |
| US-4353867-A | COMPUTERIZED QUANTITATIVE ANALYZER | LUZZANA MASSIMO | 1982-10-12 | — | — | US | disclosed |
| EP-0052718-A1 | Method and apparatus for the determination of substances in biological solutions by differential pH measurement | Luzzana, Massimo (IT) | 1982-06-02 | — | — | EP | disclosed |
| US-4282325-A | FOR AMPLIFICATION IN ASSAYS | SYVA COMPANY (US) | 1981-08-04 | — | — | US | disclosed |
| US-4203802-A | ENZYME BOUND TO AN ESTROGEN LIGAND | SYVA COMPANY (US) | 1980-05-20 | — | — | US | disclosed |
| US-4190496-A | RECEPTOR, LIGAND, AND ENZYME-BOUND | SYVA COMPANY (US) | 1980-02-26 | — | — | US | disclosed |
| US-4067774-A | Compounds for enzyme amplification assay | SYVA COMPANY (US) | 1978-01-10 | — | — | US | disclosed |
| US-3975237-A | LIGANDS | SYVA COMPANY (US) | 1976-08-17 | — | — | US | disclosed |
| US-3966556-A | Compounds for enzyme amplification assay methadone analogs | SYVA COMPANY (US) | 1976-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240238255-A1 | KL1333 FOR USE IN MEDICINE | CKMT1A; CKMT1B, SLC25A1, MT-ND3 | TP53 2722/4885TSHR 2627/4885ALDH1A1 2242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.